H.R. 3536 · 115th Congress

To require persons who undertake Federally funded research and development of drugs to enter into reasonable pricing agreements with the Secretary of Health and Human Services.

Stage
In committee
Sponsor
Peter DeFazio
Introduced
2017-07-28
Latest action
2017-08-04 · Referred to the Subcommittee on Health.

Action history

  1. 2017-08-04Referred to the Subcommittee on Health.
  2. 2017-07-28Introduced in House
  3. 2017-07-28Referred to the House Committee on Energy and Commerce.